You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
賽隆藥業(002898.SZ)擬斥1000萬元設立全資子公司
格隆匯 10-19 19:07

格隆匯 10 月 19日丨賽隆藥業(002898.SZ)公佈,公司於2020年10月19日召開了第二屆董事會第二十八次會議,審議通過了《關於設立全資子公司的議案》。公司決定以自有資金在珠海橫琴新區設立全資子公司珠海橫琴新區賽隆悦佳生物科技有限公司(公司名稱以工商登記機關核准為準)。珠海橫琴新區賽隆悦佳生物科技有限公司註冊資本為人民幣1000萬元,由公司100%持股。

珠海橫琴新區賽隆悦佳生物科技有限公司經營範圍:一般項目:人體幹細胞技術開發和應用;食品經營(銷售預包裝食品);生物化工產品技術研發;第一類醫療器械生產;第一類醫療器械銷售;第二類醫療器械銷售;化粧品批發;化粧品零售;個人衞生用品銷售;衞生用品和一次性使用醫療用品銷售;細胞技術研發和應用;技術服務、技術開發、技術諮詢、技術交流、技術轉讓、技術推廣;信息諮詢服務(不含許可類信息諮詢服務);互聯網銷售(除銷售需要許可的商品);機械設備租賃;非居住房地產租賃。(除依法須經批准的項目外,憑營業執照依法自主開展經營活動)許可項目:藥品生產;藥品批發;藥品零售;藥品委託生產;第二類醫療器械生產;第三類醫療器械經營;第三類醫療器械生產;化粧品生產;保健食品生產;保健食品銷售;食品生產;食品經營;嬰幼兒配方食品生產;特殊醫學用途配方食品生產;特殊醫學用途配方食品銷售;醫療器械互聯網信息服務;檢驗檢測服務。(依法須經批准的項目,經相關部門批准後方可開展經營活動,具體經營項目以相關部門批准文件或許可證件為準)

此次設立全資子公司符合公司自身戰略佈局和業務發展需求,是從公司的長遠利益出發所做出的慎重決策,主要目的是拓展公司生產經營領域,增強綜合競爭力。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account